US Specialty Formulations LLC
116 Research Drive
US Specialty Formulations LLC (USSF) was founded in 2013 to bring state-of-the-art quality processes to compound manufacturing. As one of the first outsourcing facilities registered with the FDA as a DQSA outsourcing facility, USSF’s mission is to provide sterile injectable solutions manufactured or compounded using validated aseptic techniques, and customized to meet the needs of each individual patient. Headquartered at Ben Franklin TechVentures in Bethlehem Pennsylvania, USSF provides compounding, contract manufacturing and filling capacity for healthcare networks, private practices, drug and vaccine development organizations.
Co-Founder and CEO: Kyle Flanigan, PhD
Co-Founder and COO: Garry Morefield, PhD
Executive Director of Quality: John Isaac, R. PH
Please click here for US Specialty Formulations' job opportunities.
Please click here for US Specialty Formulations' products.
US Specialty Formulations